BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 139 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $6,000 | -25.0% | 100 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $8,000 | +14.3% | 100 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $7,000 | -22.2% | 100 | 0.0% | 0.01% | -28.6% |
| Q2 2019 | $9,000 | +12.5% | 100 | 0.0% | 0.01% | +16.7% |
| Q1 2019 | $8,000 | +60.0% | 100 | 0.0% | 0.01% | +20.0% |
| Q4 2018 | $5,000 | -37.5% | 100 | 0.0% | 0.01% | -16.7% |
| Q3 2018 | $8,000 | +33.3% | 100 | 0.0% | 0.01% | +50.0% |
| Q2 2018 | $6,000 | -33.3% | 100 | 0.0% | 0.00% | -42.9% |
| Q1 2018 | $9,000 | +12.5% | 100 | 0.0% | 0.01% | +16.7% |
| Q4 2017 | $8,000 | +14.3% | 100 | 0.0% | 0.01% | +20.0% |
| Q3 2017 | $7,000 | +40.0% | 100 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $5,000 | +25.0% | 100 | 0.0% | 0.00% | +33.3% |
| Q1 2017 | $4,000 | +33.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $3,000 | +50.0% | 100 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |